Insulin Detemir

This page contains recent news articles, when available, and an overview of Insulin Detemir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Data Analysis Reinforces the Safety Profile of Levemir(R)  -  ‎Oct 20, 2009‎
No evidence of increased risk of malignancies in patients treated with insulin detemir: a meta-analysis. www.diabetologia-journal.org (2) Novo Nordisk data ... Reuters

IDF: Basal Insulin Regimen Superior in 4-T Study  -  ‎Oct 22, 2009‎
...wrote that the three-year efficacy of the basal insulin detemir regimen probably reflected a progressive increase in dose over that period. ... MedPage Today

Modern insulins drive up Novo Nordisk earnings  -  ‎Oct 29, 2009‎
The firm's stable of modern insulin products, including Levemir (insulin detemir) and NovoRapid (insulin aspart) contributed 5.35 billion kroner, ... Pharma Times

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes  -  ‎Oct 28, 2009‎
Patients were randomly assigned to receive biphasic insulin aspart twice daily, prandial insulin aspart three times daily, or basal insulin detemir once ... New England Journal of Medicine (subscription)

Sanofi-Aventis Delivers a Solid Performance in Third Quarter 2009  -  ‎Oct 30, 2009‎
...of the 24-hour long-acting basal insulin Lantus® administered by daily injection, versus insulin detemir administered by twice-daily injection. ... American Chronicle

Suntikan Insulin Tidak Menakutkan  -  ‎Nov 10, 2009‎
Sedangkan insulin detemir cenderung menurunkan berat badan. “Melihat kecenderungan itu, orang enggan menggunakan insulin glargine karena bisa menambah berat ... Surabaya Post

Novo-Nordisk:Novo Nordisk长效胰岛素与癌症并å?‘率较高无关  -  ‎Oct 20, 2009‎
...(NVO) 65.27 : Novo-NordISk A/S宣布,临床数æ?®åˆ†æž?结果显示,相较於人类胰岛素,Novo Nordisk长效胰岛素Levemir (insulin detemir [rDNA origin]注射季)与癌症病例 ... 凤凰网

Häufigste akute Komplikation und gefährlich für Patienten  -  ‎Nov 5, 2009‎
Was den Vergleich von NPH-Insulin und den langwirkenden Insulinanaloga anbelangt, so ist bekannt, dass unter Insulin Glargin und unter Insulin Detemir ... Diab Site

EASD: Insulin Detemir (Levemir) Provides Good Control Long Term  -  Sep 21, 2007
By Neil Osterweil, Senior Associate Editor, MedPage Today. AMSTERDAM, Sept. 21 -- Patients with type 1 diabetes who used insulin detemir (Levemir) for two ... MedPage Today

Insulin Detemir Limits Weight Gain Associated With Insulin Therapy  -  Sep 20, 2005
New data, suggest that the novel long-acting insulin, insulin detemir (Novo Nordisk) can be used in people with type 2 diabetes without causing weight gain ... Diabetes In Control

Insulin Detemir: A Long-Acting Insulin Product: Clinical Efficacy and...  -  Oct 3, 2006
Several open-label, randomized, multicenter trials (n >250) from 12 weeks to 12 months in duration have been conducted comparing the safety and efficacy of ... Medscape

Taking Insulin Detemir (rDNA Origin) Injection from Consumer Reports ...  -  Jan 10, 2006
This medication may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms. ... consumerreports.org

FDA Approves Levemir(R) (Insulin Detemir [rDNA Origin] Injection) - a...  -  Jun 17, 2005
PRINCETON, NJ, June 17 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced today that the US Food and Drug Administration (FDA) has approved Levemir(R) ... RedOrbit

… : Results from the first long-term trial: insulin detemir versus...  -  Jul 1, 2008
Results from the first long-term trial: insulin detemir versus NPH insulin in type 1 diabetes. ... find Journal of Diabetes Nursing articles. Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Insulin Detemir Safer Than NPH in Elderly Type 2's  -  Dec 11, 2007
In patients older than 65 with type 2 diabetes requiring insulin, insulin detemir may be a better choice than NPH insulin, based on an analysis of pooled ... Diabetes In Control

Learn about Insulin Detemir (rDNA Origin) Injection from Consumer …  -  Jan 10, 2006
Insulin detemir is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in ... consumerreports.org

Netherlands Corporate News - Insulin Detemir kan gewichttoename …  -  Dec 9, 2005
...( BW)(NOVO-NORDISK) Insulin Detemir Can Limit Weight Gain Associated with Insulin Therapy in Type 2 Diabetes - Particularly among the Overweight and Obese ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

Insulin detemir and insulin glargine in type 2 diabetes: head-to-head...  -  Nov 1, 2008
Insulin detemir and insulin glargine in type 2 diabetes: head-to-head comparison with once-daily administration.(Report) ... find Journal of Diabetes ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Insulin Detemir (Systemic).(Drug overview)  -  Aug 1, 2006
Insulin (IN-su-lin ) is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Comparison of Insulin Detemir and Insulin Glargine in Type 1 Diabetes  -  May 22, 2007
Treatment with twice-daily insulin detemir or once-daily insulin glargine, each in combination with insulin aspart, resulted in similar glycemic control. ... Diabetes In Control

Insulin Detemir (Systemic).  -  Oct 27, 2005
Insulin (IN-su-lin )Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Insulin Detemir  -  Jun 15, 2006
A new, long-acting insulin analog (modified, synthetic form of insulin) that acts in the bloodstream for up to 24 hours. Marketed under the brand name ... Diabetes Self Management

New Data From Head-To-Head Study Confirms Once-Daily Levemir(R) Is …  -  Jun 10, 2008
This ensured that patients included in the insulin detemir and insulin glargine ... Primary outcomes included DACON of insulin detemir or insulin glargine, ... Medical News Today - Medical News Today (press release)

New publication supports once-daily use of Levemir® in type 2...  -  Sep 3, 2007
Insulin detemir added to oral anti-diabetic drugs in type 2 diabetes provides ... Comparison of once-daily insulin detemir with NPH insulin added to a ... Healthcare Republic - Healthcare Republic

Insulin Detemir (Levemir) Poses Lower Hypoglycemia Risk Than NPH …  -  Jun 14, 2005
By Jill Stein. SAN DIEGO, CA -- June 14, 2005 -- Insulin detemir (Levemir) is associated with less risk of developing hypoglycemia than NPH insulin, ... DG News

Benefits of once-daily insulin detemir plus OADs in type 2 diabetes.(...  -  Jun 1, 2007
Benefits of once-daily insulin detemir plus OADs in type 2 diabetes.(Dialogue)(oral antidiabetic agents)(Clinical report) ... find Journal of Diabetes ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

FDA Approves Levemir (Insulin Detemir [rDNA Origin] Injection) for …  -  Oct 20, 2005
PRINCETON, NJ -- October 20, 2005 -- Novo Nordisk Inc. announced today that the US Food and Drug Administration (FDA) has approved Levemir(R) (insulin ... DG News

Putting Evidence into Practice  -  Feb 15, 2008
Based on poor quality evidence, this review suggests that insulin glargine and insulin detemir have no advantage over isophane insulin in reducing A1C ... AAFP News Now

Benefits of once-daily insulin detemir plus OADs in type 2 diabetes.(...  -  Jun 1, 2007
All insulins were injected using a pen device (FlexPen[R]; Novo Nordisk, Crawley). Due to the visually apparent differences between insulin detemir and NPH ... $4.95 - Journal of Diabetes Nursing - ECNext

Less Weight Gain With Insulin Detemir  -  Jun 27, 2006
Insulin detemir achieved target HbA1c values with less hypoglycaemia and weight gain than NPH insulin. A group of investigators led by Dr Kjeld Hermansen of ... Diabetes In Control

Article: Levemir[??][R] (insulin detemir)--tight control with reduced...  -  Apr 1, 2005
Levemir[??][R] (insulin detemir)--tight control with reduced risk of weight gain.(Dialogue)(Brief Article) ... find Journal of Diabetes Nursing articles. Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Article: Insulin detemir: a focus on the PREDICTIVE[TM] study.(Dialogu...  -  Nov 1, 2006
Insulin detemir: a focus on the PREDICTIVE[TM] study.(Dialogue) ... find Journal of Diabetes Nursing articles. Insulin detemir (Levemir[R]; Novo Nordisk, ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Changing diabetes by improving control: solutions: 4-t-the evidence...  -  Oct 1, 2008
Article: New data from diabetes UK 2009 APC meeting: insulin detemir ... ... Study examines effects of insulin detemir in routine practice . ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

New Data Confirm That Use Of Levemir® Can Limit Weight Gain  -  Apr 23, 2007
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data ... Comparison of once-daily insulin detemir with NPH insulin added to a ... Medical News Today - Medical News Today (press release)

STEPS - July 15, 2006 -- American Family Physician  -  Jul 15, 2006
Insulin detemir has the same safety concerns as other insulins, ... Most safety trials compare insulin detemir with neutral protamine Hagedorn (NPH) insulin ... AAFP News Now

Initiating basal insulin therapy in type 2 diabetes: Rosenstock et...  -  May 1, 2008
Insulin detemir is a basal insulin analogue that differs from other available basal ... of ... Article: Insulin detemir use in older people with type 2 ... ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Abstract and Introduction  -  Apr 10, 2007
The analogue insulin detemir has been reported to have a weight-sparing effect ... Patients received once- or twice-daily insulin detemir or neutral ... Medscape

New insulin helps control blood glucose levels.(BREAKING NEWS ... in ...  -  Jul 25, 2005
The recent approval of insulin detemir (Levemir) by the Food & Drug ... According to the package insert, insulin detemir is a chemically modified ... Free with registration - Drug Topics - AccessMyLibrary.com

Initiating basal insulin therapy in type 2 diabetes: Rosenstock et...  -  May 1, 2008
Baseline characteristics in the participants receiving insulin detemir (n=291) were comparable with those of the i... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

… -Acting Insulin Analog Levemir (Insulin Detemir [rDNA Origin]...  -  May 17, 2006
PRINCETON, NJ -- May 17, 2006 -- Novo Nordisk Inc. today announced that Levemir® (insulin detemir [rDNA origin] injection), a new long-acting basal insulin ... DG News

Levemir® Approved In Europe For Use In Combination With Oral …  -  Mar 12, 2007
A comparison of once-daily insulin detemir with NPH insulin when added to oral ... Safety and efficacy of insulin detemir in clinical practice: 14-week ... Medical News Today - Medical News Today (press release)

Insulin detemir (Levemir, Novo Nordisk) was approved by FDA for …  -  Nov 1, 2005
Insulin detemir (Levemir, Novo Nordisk) was approved by FDA for pediatric use. The agent was first approved in June 2005 for use in adults. ... Free with registration - Formulary - AccessMyLibrary.com

Diabetes Therapy; Insulin detemir lowers hypoglycemia risk compared …  -  Aug 29, 2006
2006 AUG 29 - (NewsRx.com) -- Insulin detemir lowers the risk of ... We investigated whether basal-bolus therapy with insulin detemir (detemir), ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Insulin detemir and insulin glargine: a head-to-head comparison with ...  -  Nov 1, 2008
Insulin detemir and insulin glargine: a head-to-head comparison with once-daily administration.(Dialogue)(Brief article) ... find Journal of Diabetes ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Levemir - Insulin Detemir (rys) - Medical Drug  -  Mar 9, 2007
Diabetes is a condition where the body is unable to convert food into usable energy, because it is unable to produce any or a sufficient amount of insulin. ... Virtual Medical Centre - The Virtual Medical Centre

FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection)  -  Jun 21, 2005
A New, Long-Acting Insulin Treatment for Diabetes. Denmark's Novo Nordisk said on Friday the United States Food and Drug Administration (FDA) has approved ... Diabetes In Control

Levemir (insulin Detemir) Reduces Weight and Improves Blood Glucose …  -  Dec 12, 2006
In the PREDICTIVE Study in a subgroup of 2377 type 2's not on insulin prior, (82%) achieved these benefits with once daily dosing of Levemir®. ... Diabetes In Control

New Data Shows That The Unique Levemir Weight Benefit Continues …  -  Sep 22, 2007
Insulin Detemir Improves Glycaemic Control, Weight and Hypoglycaemia in Patients ... Comparison of once-daily insulin detemir with NPH insulin added to a ... Medical News Today - Medical News Today (press release)

Article: The European Association for the Study of Diabetes: 41st...  -  Sep 1, 2005
Article: Benefits of once-daily insulin detemir plus OADs in . ... Conclusions: Insulin detemir is safe to use in subjects with diabetes as part of routine ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Further PREDICTIVE(R) Study Results Show Diabetes Can Be Effectively ...  -  Sep 17, 2006
Insulin analogues (insulin detemir and insulin aspart) versus traditional ... Insulin detemir and insulin glargine similar time-action profiles in subjects ... Medical News Today - Medical News Today (press release)

ADA: Patients Beat Physicians at Insulin Dose Adjustment  -  Jun 25, 2007
In the study, 5604 patients began insulin detemir as an add-on to oral ... The algorithm group was taught to adjust their dose of insulin detemir every ... MedPage Today

… : FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection)...  -  Jun 17, 2005
FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - a New, Long-Acting Insulin Treatment for Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Article: Switching from human insulins.(Dialogue) - Journal of...  -  Nov 1, 2006
...find Journal of Diabetes Nursing articles. Basal-bolus regimens: Switching from NPH to insulin detemir A subgroup analysis of the German cohort data ha... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

… : FDA Approves Levemir(R) (Insulin Detemir [rDNA Origin] Injection)...  -  Oct 20, 2005
FDA Approves Levemir(R) (Insulin Detemir [rDNA Origin] Injection) for Treatment of Diabetes in Children. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… [TM] study: results and implications for practice.(Dialogue)(insulin...  -  Jun 1, 2007
Recent results of the PREDICTIVE[TM] study showed that insulin detemir for people with ... It aimed to evaluate the safety and efficacy of insulin detemir. ... $4.95 - Journal of Diabetes Nursing - ECNext

American Diabetes Association 66th Annual Scientific Sessions: …  -  Jun 1, 2006
Subjects were given NPH insulin, insulin detemir or insulin glargine on 4 ... The efficacy of the basal analogue, insulin detemir, is considered in this ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

FDA Approvals: Hyzaar, Levemir, NovoLog/Novolin R  -  Oct 27, 2005
On Oct. 19, the FDA approved an expanded indication for insulin detemir [rDNA ... Results showed that use of insulin detemir yielded a level of glycemic ... Medscape

Type 2 Diabetes and Insulin  -  Jan 8, 2008
The newest long-acting insulin, insulin detemir, usually lasts 16–20 hours. ... Insulin detemir tends to be the most predictable of the long-acting insulins ... Diabetes Self Management

Diabetes Therapy; Insulin detemir given twice daily showed constant …  -  Jun 14, 2006
2006 JUN 14 - (NewsRx.com) -- Insulin detemir administered twice daily showed a constant metabolic effect over time under steady-state conditions. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

We stand by our results.  -  Apr 28, 2007
If insulin detemir was administered to patients with more advanced type 2 ... Comparison of insulin detemir and insulin glargine in subjects with Type 1 ... $9.94 - Chemist & Druggist - Alacra Store

… EU approval for use of Levemir[R] (insulin detemir) and NovoRapid[R...  -  Jul 1, 2005
Subjects were given NPH insulin, insulin detemir or insulin glargine on 4 occasions ... ... INFORMATION Levemir Insulin detemir Levemir Penfill Levemir ... ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Switching from human insulins.(Dialogue)  -  Nov 1, 2006
The benefits of insulin detemir highlighted previously in controlled clinical ... The use of insulin detemir is associated with significant improvements in ... $4.95 - Journal of Diabetes Nursing - ECNext

Insulin detemir (Levemir, Novo Nordisk) was approved by FDA for …  -  Nov 1, 2005
Insulin detemir will be launched for adults and children within the next 8 months, according to the company. Copyright 2005 Advanstar Communications, Inc. $9.94 - Formulary - Alacra Store

Insulin detemir: a focus on the PREDICTIVE[TM] study.(Dialogue)  -  Nov 1, 2006
Insulin detemir (Levemir[R]; Novo Nordisk, Crawley) is a long-acting modern insulin that is licensed in the UK for use as part of a basal bolus regimen in ... $4.95 - Journal of Diabetes Nursing - ECNext

insulin detemir Novo Nordisk submitted for approval, Japan (diabetes).  -  Dec 19, 2005
On 5 December 2005 Novo Nordisk submitted an NDA to the Japanese Ministry of Health, Labor and Welfare, seeking approval of insulin detemir (LEVEMIR) for ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

insulin detemir Novo Nordisk receives positive opinion for expanded...  -  Feb 28, 2005
Novo Nordisk's insulin detemir (LEVEMIR) has received a positive opinion in ... insulin detemir, NN 304, LEVEMIR, LEVEMIR PENFILL, LEVEMIR FLEXPEN, A10C, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

insulin detemir Novo Nordisk supplemental approval, USA (diabetes).  -  Oct 31, 2005
Novo Nordisk announced on 20 October 2005 that the US FDA has approved insulin detemir (LEVEMIR) for use in diabetic children. ....Insulin detemir ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Levemir[??][R] (insulin detemir)--tight control with reduced risk of...  -  Apr 1, 2005
For a long time, the price to pay for tight glycaemic control was an increased risk of hypoglycaemia. However, Professor David Matthews, Chair of the Oxford ... $4.95 - Journal of Diabetes Nursing - ECNext

ADA: Patients Beat Physicians at Insulin Dose Adjustment  -  Jun 27, 2007
Type 2 diabetes patients taught to titrate their own insulin detemir (Levemir) ... In the study, 5604 patients began insulin detemir as an add-on to oral ... Diabetes In Control

Novo Nordisk Prevails in Sanofi-Aventis Challenge to Levemir(R) -- Up...  -  Jun 27, 2006
Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal ... Levemir is contraindicated in patients hypersensitive to insulin detemir or its ... RedOrbit

New Drugs: Varenicline Tartrate, Insulin Glulisine, and Insulin...  -  Sep 25, 2006
The use of tobacco products, primarily cigarettes, represents the most preventable cause of death in the United States. Approximately 45 million American ... Medscape

New Long-Acting Insulin Analog Levemir(R) Now Available in United …  -  Mar 28, 2006
Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal ... Levemir is contraindicated in patients hypersensitive to insulin detemir or its ... RedOrbit

FDA Approvals: Levemir, Venofer, Adacel  -  Jul 7, 2005
On June 16, the FDA approved insulin detemir (rDNA origin) injection (Levemir, ... A treat-to-target efficacy study in 475 patients using insulin detemir or ... Medscape

American Diabetes Association 66th Annual Scientific Sessions.( …  -  Jun 22, 2006
Mads ... basal insulin analogues around, is insulin detemir world the ... Vice President of Novo Nordisk, insulin detemir does this more successfully than . ... Pay-Per-View - Diabetes and Primary Care - HighBeam Research

The European Association for the Study of Diabetes: 41st Annual...  -  Sep 1, 2005
Insulin detemir has been shown to limit weight gain among people with type 2 diabetes ... Those on insulin detemir had a significantly lower number of ... $4.95 - Journal of Diabetes Nursing - ECNext

… EU approval for use of Levemir[R] (insulin detemir) and NovoRapid[R...  -  Jul 1, 2005
Insulin detemir offers improved glycemic control compared with NPH insulin in ... Insulin analogues (insulin detemir and insulin aspart) versus traditional ... $4.95 - Journal of Diabetes Nursing - ECNext

InfoMedics' Patient Feedback Survey Results Published in ADA Journal,...  -  Jun 18, 2007
The survey assessed differences in self-reported perceptions of insulin detemir, a long-acting basal insulin that provides up to 24 hours of blood sugar ... prweb.com

Glycemic Control; Reports add new data to glycemic control research  -  Apr 12, 2005
Study 2: Insulin detemir reduced hypoglycemia in diabetic patients. ... Insulin detemir is a novel long-acting analogue of human insulin designed to ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

American Diabetes Association 66th Annual Scientific Sessions: …  -  Jun 1, 2006
Commenting on these results, Dr Malcolm Nattrass of University Hospital Birmingham said: 'This insight into how [insulin detemir] is being used in clinical ... $4.95 - Journal of Diabetes Nursing - ECNext

Press Release: New Study Shows A1c Reduced Safely By Patients With …  -  Jun 25, 2007
Novo Nordisk Inc. today announced that Levemir(R) (insulin detemir [rDNA origin ... The Food and Drug Administration approved Levemir (insulin detemir [rDNA ... Pay-Per-View - PR Newswire - HighBeam Research

Article: History of insulin: towards a culture of earlier intervention...  -  May 1, 2005
8) Baseline 24-Month Insulin detemir 8.30 7.36 NPH insulin 8.40 7.58 Note: table ... Insulin detemir is a long-acting ... have shown that compared with NPH ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Ann Intern Med -- Rapid Responses for Mooradian et al., 145 (2) 125...  -  Sep 8, 2006
In contrast, both insulin glargine and insulin detemir showed a ... It is also noteworthy that insulin detemir was shown to be associated with a lower ... Annals of Internal Medicine

Traditional Insulin Compares Well Against Analogs  -  Apr 18, 2007
Neither insulin glargine (Lantus) nor insulin detemir (Levemir) were superior to NPH (neutral protamine Hagedorn, or isophane) insulin at protecting against ... MedPage Today

Article: Levemir, Trileptal.(New & Approved) - Family Practice News |...  -  Jan 1, 2006
New & Approved) ... find Family Practice News articles. Levemir (insulin detemir [rDNA origin] injection, Novo Nordisk Inc.) The Food and Drug... Pay-Per-View - Family Practice News - HighBeam Research

Appropriate use of insulin analogs in an increasingly complex type 2 ...  -  Jan 1, 2007
Insulin detemir activity peaks at approximately 8 hours, ... (22) Addition of NPH insulin or insulin detemir twice daily to existing OAD treatment in ... $4.95 - Journal of Family Practice - ECNext

New Studies Showed FlexPen ® Was Superior to SoloSTAR ® in Dose …  -  May 20, 2008
At both doses measured, Levemir® (insulin detemir [rDNA origin] injection) FlexPen® accurately delivered insulin with fewer deviations than Lantus® ... marketwire.com

Treating diabetes: addressing a weighty problem  -  Jul 25, 2007
Rašlová K et al, Insulin detemir and insulin aspart: a promising ... Home et al, Insulin detemir offers improved glycemic control compared with NPH insulin ... responsesource.com

International Approvals: Levemir, Plavix, Celsentri  -  Oct 29, 2007
October 29, 2007 — The Japanese Ministry of Health, Labor, and Welfare has approved insulin detemir injection for the treatment of types 1 and 2 diabetes, ... Medscape

Article: Levemir, Rozerem.(New & Approved) - Family Practice News | …  -  Aug 15, 2005
New & Approved) ... find Family Practice News articles. Levemir (insulin detemir [rDNA origin] injection, Novo Nordisk) A long-acting basal... Pay-Per-View - Family Practice News - HighBeam Research

International Approvals: Levemir, Thelin, Sebivo  -  Mar 9, 2007
Insulin detemir was previously approved by the EC and the US Food and Drug Administration for once- or twice-daily use in the treatment of adult and ... Medscape

Article: Case study 3: diabetes and mental health. - Journal of...  -  May 1, 2005
2004 ABBREVIATED PRESCRIBING INFORMATION FOR LEVEMIR[R] (INSULIN DETEMIR ... Novo Nordisk Inc. today announced that Levemir(R) (insulin detemir [rDNA origin ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Treatments and devices for future diabetes management.  -  May 3, 2005
Insulin detemir has also been designed to have a more consistent rate of absorption ... Insulin detemir is currently only licensed for use in a basal-bolus ... Nursing Times

Better Strategies Sought Against Obesity  -  Oct 4, 2006
But treatment with the insulin analogue insulin detemir, which consists of an ... Niswender wondered whether insulin detemir might be preventing excess ... Journal of American Medical Association - Journal of American Medical Association...

Periodontal Disease Linked to Mortality in Type 2 Diabetes  -  Jun 7, 2005
FACT: Pharmacodynamics of insulin detemir compared with NPH insulin: A group ... The researchers found that insulin detemir 0.29units/kg provided the same ... Diabetes In Control

Selected biotechnology, biotech-related, small-molecule and other FDA...  -  Feb 27, 2006
...hormone (GH) gene deletion who have developed neutralizing antibodies to GH Levemir Treatment of diabetes mellitus (insulin detemir [rDNA origin](type 1 ... Pay-Per-View - Chain Drug Review - HighBeam Research

Initiating basal insulin therapy in type 2 diabetes: the evidence...  -  May 1, 2008
Insulin detemir: evidence, efficacy and applications.(Insulin) Journal of Diabetes Nursing; November 1, 2004 ; 700+ words ... ... glycaemic targets. ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Sales Up 9.7% in 2005 Targeting Diabetes: Novo Nordisk  -  Mar 27, 2006
Insulin detemir is a soluble basal insulin analogue with a mechanism of protraction which provides a smooth and predictable action profile and offers a ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

Management of diabetes-related hypoglycemia.(Review Article)(Disease/...  -  Feb 1, 2007
...(77) Insulin detemir has a unique dual mechanism of protraction. First, unlike insulin glargine, insulin detemir is soluble at neutral pH and undergoes ... Free with registration - Southern Medical Journal - AccessMyLibrary.com

Levemir(R) Helps Patients Significantly and Safely Improve Control in...  -  Jun 12, 2006
Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal ... Levemir is contraindicated in patients hypersensitive to insulin detemir or its ... Free with registration - PR Newswire - AccessMyLibrary.com

Univ. of Arkansas for Medical Sciences; Reports add new data to …  -  Apr 13, 2005
Study 2: Insulin detemir reduced hypoglycemia in diabetic patients. ... Insulin detemir is a novel long-acting analogue of human insulin designed to ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Press Release: Levemir(R) Helps Patients Significantly and Safely …  -  Jun 12, 2006
S. and is used with Novo Nordisk's NovoLog(R) Mix ... to-be-launched Levemir(R) (insulin detemir ... insulin products. Novo Nordisk is a healthcare company ... Pay-Per-View - PR Newswire - HighBeam Research

Glycemic Control; New findings in glycemic control described  -  Apr 26, 2005
Study 3: Insulin detemir reduced hypoglycemia in diabetic patients. ... Insulin detemir is a novel long-acting analogue of human insulin designed to ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

American Diabetes Association 66th Annual Scientific Sessions.( …  -  Jun 22, 2006
Commenting on these results, Dr Malcolm Nattrass of University Hospital Birmingham said: 'This insight into how [insulin detemir] is being used in clinical ... $4.95 - Diabetes and Primary Care - ECNext

Merger and Acquisition Scenario  -  Nov 22, 2008
NovoSeven (Recombinant Coagulation Factor VIIa); NovoLog Mix 70/30 (Insulin Aspart); NovoMix 50 (Insulin Aspart Mixture); Levemir (Insulin Detemir) ... $250.00 - Revere Reports - Revere

Management of diabetes-related hypoglycemia.(Review Article)(Disease/...  -  Feb 1, 2007
...(77) Insulin detemir has a unique dual mechanism of protraction. First, unlike insulin glargine, insulin detemir is soluble at neutral pH and undergoes ... $4.95 - Southern Medical Journal - ECNext

Merger and Acquisition Scenario  -  Dec 27, 2008
NovoSeven (Recombinant Coagulation Factor VIIa); NovoLog Mix 70/30 (Insulin Aspart); NovoMix 50 (Insulin Aspart Mixture); Levemir (Insulin Detemir) ... $250.00 - Revere Reports - Revere

Novo Nordisk Becomes Insulin Market Leader.  -  Nov 10, 2005
Additionally, we anticipate further growth with the launch of Levemir(R) (insulin detemir [rDNA origin] injection) in 2006. Treating patients with our full ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: One Year Study of Exenatide Treatment Showed …  -  Sep 21, 2007
Article: Study shows insulin detemir results in less variability in blood ... ... (Logo: http://www.newscom ... insulin detemir, NPH insulin, ... Pay-Per-View - PR Newswire - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy